Carl Freer

Last updated

Carl Freer
Carl Freer.jpg
Freer in February 2012
Born
Carl Johan Freer
NationalitySwedish
Occupation(s)Entrepreneur, businessman

Carl Johan Freer is a Swedish businessman and technology entrepreneur primarily known for founding the American company Tiger Telematics, which created the handheld game console Gizmondo. [1] [2] Freer is also the founder of Singapore-based medical-device company, Aluminaid and co-author of several patents. [3] [4]

Contents

Business ventures

The earlier part of Carl’s career was focused on disruptive software companies. [5] Freer founded Tiger Telematics, an electronics company that launched in 2002, raised over £160 million, and reached a market cap over $1 billion [6] before it dissolved in 2006. [7] He managed the development, launch and promotion of the Gizmondo. Freer was Chairman of the Tiger Telematics board of directors until he resigned [8] in October 2005 pending publication of an article in the Swedish press. [9] [10] By 6 February 2006, the company was forced into compulsory liquidation and Gizmondo was discontinued. [11] [12]

Other ventures included Xero Mobile—which had a service that automatically billed advertisers based on the number of marketing messages viewed by users—and Getfugu, which developed an application that enabled consumers to retrieve web content without typing a website address or search term into a browser. [13] [14] Freer co-founded a crowdsourcing networking website for filmmakers, financiers, actors and fans called FilmFunds as well as the Family Tree Foundation. [15] [16] [17]

In 2008, Carl Freer hosted a seminar at Georgia Institute of Technology entitled "High Tech Ventures in Mobile Gaming and Media". Freer discussed his experiences, his plans for a potential rebirth of Gizmondo as well as his plans for the development of new mobile video technologies. The event took place as part of GA Tech's GVU Center Lecture series. [18] [19] [20] Later that year, a relaunch of Gizmondo was aborted. [21] In 2010, Freer co-founded Aluminaid, which makes metal-based bandages to relieve pain in patients with first- and second-degree burns. [4]

Freer is from a computational science background focusing on the biotech domain. In 2008, he, along with Richard Grossman and Tom Brady, founded Aluminaid, a medical device company that developed a patented burn dressing. The company relocated to Singapore’s Biopolis Biotech park and produced wound care products and first-aid kits for burns treatment. [5] [22]

In 2020, Carl Freer founded Cellvera, a company dedicated to the research and development of oral treatments for viral diseases. The firm expanded its operations through a licensing agreement with FujiFilm Toyama for the production and distribution of AVIGAN, a decision that contributed to a notable increase in revenue from $9 million in 2020 to an estimated $100 million in 2021. Cellvera's focus includes advancing treatments for various life-threatening viruses, reflecting its commitment to addressing global health challenges. [23] [24]

Freer founded Prepaire Labs as an effort to integrate artificial intelligence (AI) and data science into the drug development process. The initiative collaborates with academic and research institutions to apply advances in genome research, notably CRISPR technology. Prepaire Labs aims to optimize the drug development pipeline by facilitating target identification, lead discovery, optimization, drug synthesis, and pre-clinical testing, thereby seeking to enhance efficiency in developing treatments for various diseases. [25]

In February 2024, on behalf of Prepaire Labs, Freer entered into a strategic partnership with MGI, announced at MEDLAB Middle East 2024, aimed at advancing drug discovery and precision medicine. This collaboration marked the introduction of MGI's DNBSEQ-T20×2 sequencer to the Middle East, emphasizing the enhancement of genomics research and personalized medicine through advanced sequencing technology. [26]

Patents

Carl Freer has been granted several patents in the fields of technology and pharmaceuticals:

  1. Multimedia Content Transmission System: US Patent 10,628,856 B2, granted on April 21, 2020, presents a method for transmitting multimedia content effectively over telecommunications networks. It introduces novel applets for decrypting and scheduling playback on mobile platforms, along with feedback mechanisms to improve user engagement and advertiser benefits. [27]
  2. Antiviral and Antiparasitic Pharmaceutical Combination: US Patent 11,446,320 B1, issued on September 20, 2022, describes a pharmaceutical composition that combines favipiravir and ivermectin for the treatment of single-stranded RNA viruses, including SARS-CoV-2. [28]
  3. Diagnostic and Treatment System for RNA Viruses: US Patent 11,439,638 B1, granted on September 13, 2022, outlines a system for the diagnosis and treatment of RNA viruses, with a focus on coronaviruses. [29]
  4. Thermally Conductive Metal-Based Bandages for Medical Healing: US Patent 9271875B2 details a method for creating bandages from thermally conductive metal, such as aluminum, designed to treat burns and other skin injuries by promoting faster cooling and healing through direct contact with the wound. [30]

Freer has been arrested by police in Sweden, Spain, Germany, the UK and the USA. He has used aliases: Eric Jonsson and Brian Littleton. [31]

Freer's business partners, Stefan Eriksson and Mikael Ljungman, have both been convicted of fraud. [32]

Carl Freer was at the helm of Gizmondo Europe Limited during one of the biggest company fraud investigations in recent British history, totaling 215 million pounds (UK). [33]

In 2005, Freer was fined £135,000 by a court in Stuttgart, Germany for canceling check payments in a transaction with a car dealer. [10] Freer claimed he cancelled the cheques because he "thought he was being sold stolen cars". [1] [34] [35]

In 2006, no charges were filed after Los Angeles police found a collection of twelve rifles and four handguns at Freer's home in an investigation that led to his arrest on suspicion of impersonating a San Gabriel Valley Transit Authority police officer to buy a .44 Magnum handgun. Authorities dropped the investigation after Freer established that he did not impersonate a police officer and showed a valid gun permit. [10] [34] [36]

In 2009, the law firm Patton Boggs, on behalf of clients David Warnock and Simon Davies, filed an action alleging violations of the civil RICO Act against GetFugu, Carl Freer, and other officers and directors of GetFugu. [37] The firm followed the lawsuit with a press release that falsely claimed that GetFugu and Carl Freer were being investigated by the FBI. [38] In 2010, on a motion by GetFugu, District Court Judge George H. King dismissed Patton Boggs' claims with prejudice. [37] [39] GetFugu and Freer then countersued Patton Boggs for defamation and malicious prosecution, seeking damages of over $500 million. Patton Boggs filed a special motion to strike the defamation claim, contending that the press release regarding the alleged FBI investigation, even if false, was protected by litigation privilege, [37] [39] but the California Court of Appeals disagreed, allowing Freer and GetFugu to proceed with the $500 million lawsuit against Patton Boggs. [39] Patton Boggs' special motion to strike the malicious prosecution claim was also denied, holding that Patton Boggs did not have probable cause to prosecute the RICO claims. [37] [39]

In October 2015, Carl Freer unsuccessfully sued Danish Television Channel DR3 to have his name removed from a documentary on the Stein Bagger IT Factory fraud case prior to broadcast. [40] Following the documentary broadcast, he filed defamation claims against 5 employees of DR. [41]

See also

Related Research Articles

<span class="mw-page-title-main">Complementary DNA</span> DNA reverse transcribed from RNA

In genetics, complementary DNA (cDNA) is DNA that was reverse transcribed from an RNA. cDNA exists in both single-stranded and double-stranded forms and in both natural and engineered forms.

<span class="mw-page-title-main">Interferon</span> Signaling proteins released by host cells in response to the presence of pathogens

Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.

<span class="mw-page-title-main">Antiviral drug</span> Medication used to treat a viral infection

Antiviral drugs are a class of medication used for treating viral infections. Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. Antiviral drugs are a class of antimicrobials, a larger group which also includes antibiotic, antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from virucides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural virucides are produced by some plants such as eucalyptus and Australian tea trees.

<i>Rotavirus</i> Specific genus of RNA viruses

Rotaviruses are the most common cause of diarrhoeal disease among infants and young children. Nearly every child in the world is infected with a rotavirus at least once by the age of five. Immunity develops with each infection, so subsequent infections are less severe. Adults are rarely affected. Rotavirus is a genus of double-stranded RNA viruses in the family Reoviridae. There are nine species of the genus, referred to as A, B, C, D, F, G, H, I and J. Rotavirus A is the most common species, and these rotaviruses cause more than 90% of rotavirus infections in humans.

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science.

<span class="mw-page-title-main">Sedoreoviridae</span> Family of viruses

Sedoreoviridae is a family of double-stranded RNA viruses. Member viruses have a wide host range, including vertebrates, invertebrates, plants, protists and fungi. They lack lipid envelopes and package their segmented genome within multi-layered capsids. Lack of a lipid envelope has allowed three-dimensional structures of these large complex viruses to be obtained, revealing a structural and likely evolutionary relationship to the cystovirus family of bacteriophage. There are currently 97 species in this family, divided among 15 genera in two subfamilies. Reoviruses can affect the gastrointestinal system and respiratory tract. The name "reo-" is an acronym for "respiratory enteric orphan" viruses. The term "orphan virus" refers to the fact that some of these viruses have been observed not associated with any known disease. Even though viruses in the family Reoviridae have more recently been identified with various diseases, the original name is still used.

<i>Feline leukemia virus</i> Species of virus

Feline leukemia virus (FeLV) is a retrovirus that infects cats. FeLV can be transmitted from infected cats when the transfer of saliva or nasal secretions is involved. If not defeated by the animal's immune system, the virus weakens the cat's immune system, which can lead to diseases which can be lethal. Because FeLV is cat-to-cat contagious, FeLV+ cats should only live with other FeLV+ cats.

<span class="mw-page-title-main">Gizmondo</span> Handheld game console (2005–2006)

The Gizmondo is a handheld gaming console developed by Tiger Telematics. It was released in the UK, Sweden and the U.S. starting in March 2005. Its first-party games were developed in studios in Helsingborg, Sweden, and Manchester, England. Gizmondo Europe, Ltd. was based in London, England, and was a subsidiary of Florida-based Tiger Telematics, whose chairman Carl Freer led Gizmondo's development.

Venezuelan hemorrhagic fever (VHF) is a zoonotic human illness first identified in 1989. The disease is most prevalent in several rural areas of central Venezuela and is caused by Guanarito mammarenavirus (GTOV) which belongs to the Arenaviridae family. The short-tailed cane mouse is the main host for GTOV which is spread mostly by inhalation of aerosolized droplets of saliva, respiratory secretions, urine, or blood from infected rodents. Person-to-person spread is possible, but uncommon.

<span class="mw-page-title-main">Squire Patton Boggs</span> Global law firm

Squire Patton Boggs is an international law firm with over 40 offices in 20 countries. It was formed in 2014 by the merger of multinational law firm Squire Sanders with Washington, D.C. based Patton Boggs. It is one of the largest law firms in the world by total headcount and gross revenue, twelfth largest firm in the UK by revenue, and one of the top 12 by number of countries occupied.

<span class="mw-page-title-main">Tiger Telematics</span> Swedish electronic company

Tiger Telematics, or Tiger, was a Swedish electronics company, best known for the failed Gizmondo handheld game console.

Bo Stefan M. Eriksson is a Swedish video game developer and criminal from Uppsala involved in the British gaming company Gizmondo with his business partner Carl Freer, until it became insolvent in 2005. In February 2006, he became known for wrecking an Enzo Ferrari in Malibu, California, USA. He was the leader of the loose criminal organization "Uppsalamaffian" until he began to develop the Gizmondo.

Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). There is some evidence it may improve some ME/CFS symptoms.

<span class="mw-page-title-main">Ronald Plasterk</span> Dutch politician and scientist (born 1957)

Ronald Hans Anton Plasterk is a Dutch retired politician of the Labour Party (PvdA). He has a PhD degree in biology, specialising in molecular genetics. He is founder and CEO of Frame Cancer Therapeutics. He was appointed professor at the University of Amsterdam in September 2018.

Mikael Ljungman is a Swedish politician, lawyer and businessman. He was 2009–2010 convicted of fraud and false accounting related to his business activities, for which he served a two-year prison term. He is also known for his association and involvement with two high-profile tech failures: the game console manufacturer Gizmondo in 2005 and IT Factory in 2008. After his release from prison, Ljungman became active in the Christian Democrats legal policy network. He was selected as a Christian Democrats parliamentary candidate for the 2014 Swedish elections, as number 32 on their Stockholm candidate list.

<span class="mw-page-title-main">Sofosbuvir</span> Chemical compound

Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used to treat hepatitis C. It is taken by mouth.

Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development, vaccines and genome editing. HSV-1 and HSV-2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox (varicella/zoster), cytomegalovirus, and Epstein-Barr virus. There are many more virus members that infect animals other than humans, some of which cause disease in companion animals or have economic impacts in the agriculture industry.

JK-05 is a broad-spectrum antiviral drug developed by the Chinese company Sihuan Pharmaceutical along with the Chinese Academy of Military Medical Sciences. It is reported to act as an inhibitor of the viral enzyme RNA polymerase which is essential for viral replication. In tests on mice, JK-05 was claimed to show efficacy against a range of RNA viruses, including influenza, Ebola virus and yellow fever, as well as several arenaviruses and bunyaviruses. The chemical structure of JK-05 has not been disclosed as of October 2014, but it is claimed to be a small molecule drug with a comparatively simple structure, which should be readily amenable to synthesis scale-up for mass production if testing is successful. The drug is however admitted to be similar to the Japanese anti-influenza drug favipiravir, developed by Fujifilm Holdings Corp, which has been used effectively to treat patients with Ebola. In addition, WHO committee members mentioned that the drug is a copy product of favipiravir, because patents of favipiravir were already registered in 2006 in China. The drug has been given preliminary approval by the Chinese authorities to be available for Chinese health workers involved in combating the 2014 West African Ebola outbreak, or if Ebola were to spread into mainland China. Several other Chinese developed antiviral drugs with anti-Ebola activity have also been disclosed, but have not progressed so far through development as JK-05.

<span class="mw-page-title-main">GS-441524</span> Metabolite of remdesivir

GS-441524 is a nucleoside analogue antiviral drug which was developed by Gilead Sciences. It is the main plasma metabolite of the antiviral prodrug remdesivir, and has a half-life of around 24 hours in human patients. Remdesivir and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats. Remdesivir was never tested in cats, but GS-441524 has been found to be effective treatment for FIP.

<span class="mw-page-title-main">Zhang Yongzhen</span> Chinese virologist

Zhang Yongzhen, also known as Yong-Zhen Zhang, is a Chinese virologist known for his work relating to the COVID-19 pandemic. A professor at Fudan University, Zhang has discovered numerous RNA viruses and created a network of labs dedicated to monitoring new viruses. He led the team that sequenced and published the genome of SARS-CoV-2, the virus that causes COVID-19, in early January 2020.

References

  1. 1 2 Jeffrey Fleishman; Richard Winton (15 May 2006). "Life in Fast Lane Long Before the Ferrari Crash". Los Angeles Times .
  2. ↑ Gibson, Ellie (6 August 2012). "A Horse named Gizmondo: The Inside Story of the World's Greatest Failed Console". Eurogamer. Retrieved 10 January 2014.
  3. ↑ "How to treat burns". Esquire Magazine – Malaysia Ed. Archived from the original on 24 September 2015. Retrieved 1 July 2015.
  4. 1 2 "Aluminaid: The New Frontier of Aluminum". King's Road Magazine. Retrieved 3 August 2015.
  5. 1 2 "Carl Freer Announces Clinical Trials on Patented Burn Dressing". PRWeb. Retrieved 29 December 2022.
  6. ↑ Taub, Eric A. (8 February 2006). "Game Maker Finds Itself Short of Cash and Admirers". The New York Times. Retrieved 4 November 2015.
  7. ↑ "Bad Tech: CEOs who fell from grace". T3. 22 March 2012. Retrieved 15 March 2015.
  8. ↑ "Life in Fast Lane Long Before Ferrari Crash". Los Angeles Times. 15 May 2006. Retrieved 12 May 2015.
  9. ↑ Smith, Tony (27 October 2005). "Gizmondo executives quit under cloud". The Register.
  10. 1 2 3 Randall Sullivan (1 October 2006). "Gizmondo's Spectacular Crack-up". Wired .
  11. ↑ "Gizmondo Europe goes into liquidation". Pocket-Lint. 7 February 2006. Archived from the original on 13 September 2012. Retrieved 14 January 2013.
  12. ↑ Snow, Blake (7 June 2011). "The 10 Worst Selling Handhelds Of All Time". GamePro. Archived from the original on 7 June 2011. Retrieved 14 January 2013.
  13. ↑ "Carl Freer bakom nytt miljardbolag". Archived from the original on 23 August 2014. Retrieved 7 September 2014.
  14. ↑ "Augmented Reality Makes Commercial Headway". Scientific American. Retrieved 15 October 2014.
  15. ↑ "FilmFunds Acquires 3D Conversion Specialists Duran Duboi U.S." The Hollywood Reporter. 20 December 2011. Retrieved 27 December 2011.
  16. ↑ "FilmFunds to Use Crowdsourcing to Pitch 3D Conversions (Exclusive)". The Wrap Covering Hollywood. The Wrap News Inc. 20 December 2011. Retrieved 30 December 2011.
  17. ↑ "FilmFunds buys post house – Crowdsourcing venture wants to be one-stop shop". Variety . 20 December 2011. Retrieved 30 December 2011.
  18. ↑ smith, Tony (13 May 2008). "Gizmondo console revamp 'on track' for Q4 launch, claims boss". The Register.
  19. ↑ "GVU Brown Bag – Carl Freer". Georgia Tech GVU Center. Archived from the original on 9 May 2016. Retrieved 8 April 2016.
  20. ↑ Fahey, Mike (6 March 2008). "Liveblogging The Gizmondo GA Tech Lecture". Kotaku.
  21. ↑ Gillett, Nick (10 January 2009). "Games news: Gizmondo 'relaunch' off". The Guardian.
  22. ↑ "Carl Freer's Aluminaid Bandages Changing the Way Burn Victims Are Treated". GlobeNewswire News Room. 15 December 2015. Retrieved 29 December 2022.
  23. ↑ brien, mary o (22 April 2022). "Cellvera Announce 2021 total sales of 100M$ and Audited Accounts with Revenues of $50M". EIN Presswire. Retrieved 12 February 2024.
  24. ↑ brien, mary o (22 April 2022). "World's Largest Meta-Analysis of Favipiravir Data Demonstrates Significant Clinical Improvements in COVID-19 Patients". EIN Presswire. Retrieved 12 February 2024.
  25. ↑ "Chemify Partners with Prepaire Labs to Apply Ground-breaking Chemistry AI-Robotics to Radically Accelerate the Discovery of Non-Addictive Opioids". Yahoo Finance. 18 January 2024. Retrieved 12 February 2024.
  26. ↑ MGI. "MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine". www.prnewswire.co.uk. Retrieved 12 February 2024.
  27. ↑ US10169780B2,Freer, Carl J.,"System and method for transmitting and receiving multimedia content",issued 2019-01-01
  28. ↑ "Google Patents". patents.google.com. Retrieved 9 February 2024.
  29. ↑ US11446320B1,Freer, Carl Johan; Kaszynski, Richard& Gadotti, Alessandro,"Pharmaceutical combination having potent antiviral activity against single-stranded RNA viruses",issued 2022-09-20
  30. ↑ "Carl Freer Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 9 February 2024.
  31. ↑ [source realtid.se published 2009/04/16] (
  32. ↑ [Reference: realtid.se & planesite legal document California Central District Court case number: 2:09/cv/08724 Simon Davies et al. v. Getfugu Inc. et al.http://www.realtid.se/carl-freer-bakom-nytt-miljardbolag
  33. ↑ "The Times & the Sunday Times".[ dead link ]
  34. 1 2 Anthony James, Michael Gillard (21 May 2006). "The firm that blew it all in two years". The Sunday Times . London. Archived from the original on 12 February 2007.
  35. ↑ "Freer Dreamed of an Empire". Ekonomi. 28 April 2006. Retrieved 1 October 2014.
  36. ↑ Richard Winton; David Pierson (27 April 2006). "2nd Arrest Made in Ferrari Case". Los Angeles Times . Retrieved 9 December 2011.
  37. 1 2 3 4 "Lessons From Patton Boggs Defamation Case". Law360. 26 November 2013. Retrieved 14 January 2014.(subscription required)
  38. ↑ "Patton Boggs Settles with Chevron". The Hill. 7 May 2014. Retrieved 30 January 2016.
  39. 1 2 3 4 Hansen, Mark T.; Robert B. Milligan (25 October 2013). "Allegedly false statements posted on internet regarding pending litigation can support defamation claim". Lexology. Retrieved 14 January 2014.
  40. ↑ Nielsen, Silas Bay. "Byret giver DR3 grønt lys til at sende Stein Bagger-dokumentar" [City Court gives DR3 green light to broadcast Stein Bagger documentary] (in Danish). DR.dk.
  41. ↑ Lohse, Gregers. "Fem DR-medarbejdere stævnet for Stein Bagger-serie" [Five DR-employees sued for Stein Bagger Series] (in Danish). DR.dk.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.